Theralase Technologies Inc (TLT.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 269 | 44 | 1,509 | 3,692 | 7,880 |
| Receivables | 712 | 599 | 437 | 300 | 485 |
| Inventories | 545 | 658 | 486 | 566 | 452 |
| Other current assets | 58 | 198 | 70 | 440 | 98 |
| TOTAL | $1,584 | $1,499 | $2,501 | $4,998 | $8,916 |
| Non-Current Assets | |||||
| PPE Net | 606 | 858 | 1,107 | 866 | 1,041 |
| Other Non-Current Assets | 1,057 | 920 | 553 | 81 | 64 |
| TOTAL | $1,663 | $1,778 | $1,660 | $947 | $1,105 |
| Total Assets | $3,247 | $3,277 | $4,161 | $5,945 | $10,021 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 362 | 682 | 328 | 496 | 408 |
| Accrued Expenses | 523 | 280 | 267 | 343 | 357 |
| TOTAL | $986 | $1,077 | $681 | $875 | $821 |
| Non-Current Liabilities | |||||
| TOTAL | $194 | $294 | $387 | $0 | $36 |
| Total Liabilities | $1,180 | $1,371 | $1,068 | $875 | $857 |
| Shareholders' Equity | |||||
| Common Shares | 48,924 | 46,436 | 44,527 | 42,120 | 42,120 |
| Retained earnings | -67,496 | -63,240 | -58,452 | -53,092 | -48,506 |
| Other shareholders' equity | 3,058 | 6,219 | 5,643 | 5,098 | 5,295 |
| TOTAL | $2,067 | $1,905 | $3,093 | $5,070 | $9,164 |
| Total Liabilities And Equity | $3,247 | $3,277 | $4,161 | $5,945 | $10,021 |